"The lawsuit argues that drug makers used false and misleading claims to push their products, such as down-playing the risk of addiction; claiming that it is easy to manage opioid dependence and withdrawal; and denying risks from using higher doses of the drugs," Estep reports. "It also alleges the companies targeted vulnerable patient populations, including people served by rural health clinics in Appalachia. There is a high prevalence of “societal risk factors which contribute to an increased and widespread abuse of opioids” in the region, the lawsuit says, including lower income; lower educational attainment; depression; a higher portion of jobs prone to injuries; and poor health status."
The suit claims distributors of the drugs failed "to stop suspiciously large shipments of painkillers and by not reporting red flags about possible diversion of prescription pills to the government as required," Estep reports. It says addiction to opioids "drives up costs for rural health clinics, not just for providing treatment but for added needs such as regulatory compliance and security; lost employee productivity; and having to kick out patients for abusing or diverting prescribed drugs."